RxSight CMO sells 5,100 shares to cover RSU taxes
RxSight’s chief medical officer reported RSU vesting, a related tax withholding sale, and substantial indirect holdings via Cricklewood LP.
Rhea-AI Filing Summary
RxSight, Inc. (RXST) reported that Chief Medical Officer Ronald M. Kurtz, MD had 13,425 Restricted Stock Units vest on August 31, 2026, converting into 13,425 shares of common stock. On the same date, he continued to hold 67,120 RSUs directly. On September 2, 2026, 5,100 common shares were sold at $6.96 per share to satisfy tax withholding obligations related to this RSU vesting, which the company notes did not represent a discretionary sale. Separately, 764,610 common shares are held indirectly through Cricklewood LP, an entity over which Dr. Kurtz shares voting and investment control with his spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F2 | 5,100 | $6.96 | $35K |
| Exercise | Restricted Stock Unit F1, F4 | 13,425 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 13,425 | -- | -- |
| holding | Common Stock F3 | -- | -- | -- |
Footnotes (4)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- F2. Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person.
- F3. Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.
- F4. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029.
Key Figures
Key Terms
Restricted Stock Unit financial
tax withholding obligations financial
Service Provider financial
Trading Day financial
Equity Incentive Plan financial
FAQ
What insider transactions did RxSight (RXST) report for Ronald M. Kurtz, MD?
How many Restricted Stock Units does the RxSight (RXST) CMO still hold after these transactions?
Was the RxSight (RXST) insider sale made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.